Jaguar Health, Inc. (JAGX)
NASDAQ·Healthcare·Biotechnology
$0.31
-1.54%
Mkt Cap $1.07M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$3.21
Range $3.21 – $3.21
Implied Upside
+922.0%
Consensus $3.21 vs current $0.31
NASDAQ·Healthcare·Biotechnology
$0.31
-1.54%
Mkt Cap $1.07M
No recent rating data.
Price Target (2 analysts)
$3.21
Range $3.21 – $3.21
+922.0%
Consensus $3.21 vs current $0.31